{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Verbascoside", "WEE1", "miR-101-3p", "proliferation", "radiosensitivity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35080031", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "26"}], "Language": ["eng"], "ELocationID": ["10.1002/ddr.21914"], "Journal": {"ISSN": "1098-2299", "JournalIssue": {"Volume": "83", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Jun"}}, "Title": "Drug development research", "ISOAbbreviation": "Drug Dev Res"}, "ArticleTitle": "Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR-101-3p/Wee1 axis.", "Pagination": {"StartPage": "891", "EndPage": "899", "MedlinePgn": "891-899"}, "Abstract": {"AbstractText": ["Verbascoside is a kind of phenylpropanoid glycoside derived from multiple medicinal plants, exerting anti-tumor effects in diverse human malignancies. However, the function of Verbascoside on the radiosensitivity of hepatocellular carcinoma (HCC) cells remains unknown. Human Huh7 and HepG2 cell lines were treated with Verbascosideis, and cell viability was detected with cell counting kit-8 (CCK-8) assay. Quantitative real-time polymerase chain reaction (qRT-PCR) was applied to detect miR-101-3p expression, and Western blot was used to quantify the expression of WEE1 G2 checkpoint kinase (WEE1). Then, CCK-8 and flow cytometry assays were used to detect the proliferation and apoptosis of HCC cells after Verbascoside and X-ray combined treatment, and the expressions of WEE1 and apoptosis-related proteins Bax and Bcl-2 were detected by Western blot. Verbascoside could improve the radiosensitivity of HCC cells in a dose-dependent manner. Verbascoside increased the expression of miR-101-3p but reduced WEE1 expression in HCC cells. Additionally, WEE1 was identified as a target of miR-101-3p. MiR-101-3p inhibition or WEE1 overexpression could reverse the effect of Verbascoside on the viability and apoptosis of HCC cells. Verbascoside increases the radiosensitivity of hepatocellular carcinoma cells via modulating miR-101-3p/WEE1 axis."], "CopyrightInformation": "\u00a9 2022 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China."}], "LastName": "Sun", "ForeName": "Lin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China."}], "LastName": "Cai", "ForeName": "Huangxing", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China."}], "LastName": "Zhou", "ForeName": "Tengchao", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China."}], "LastName": "Xiang", "ForeName": "Hua", "Initials": "H"}, {"Identifier": ["0000-0001-9106-7240"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China."}], "LastName": "Long", "ForeName": "Lin", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Drug Dev Res", "NlmUniqueID": "8204468", "ISSNLinking": "0272-4391"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cell Cycle Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN101 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenols"}, {"RegistryNumber": "3TGX09BD5B", "NameOfSubstance": "acteoside"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Protein-Tyrosine Kinases"}, {"RegistryNumber": "EC 2.7.10.2", "NameOfSubstance": "WEE1 protein, human"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "genetics", "radiotherapy"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Cell Cycle Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glucosides"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "genetics", "radiotherapy"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["genetics"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phenols"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Protein-Tyrosine Kinases"}, {"QualifierName": [], "DescriptorName": "Radiation Tolerance"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alipieva, K., Korkina, L., Orhan, I. E., & Georgiev, M. I. (2014). Verbascoside-a review of its occurrence, (bio)synthesis and pharmacological significance. Biotechnology Advances, 32(6), 1065-1076. https://doi.org/10.1016/j.biotechadv.2014.07.001"}, {"Citation": "Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424. https://doi.org/10.3322/caac.21492"}, {"Citation": "Chen, L. C., Lin, H. Y., Hung, S. K., Chiou, W. Y., & Lee, M. S. (2021). Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World Journal of Gastroenterology, 27(20), 2434-2457. https://doi.org/10.3748/wjg.v27.i20.2434"}, {"Citation": "Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., \u2026 He, J. (2016). Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66(2), 115-132. https://doi.org/10.3322/caac.21338"}, {"Citation": "Chen, X., & Zhang, N. (2019). Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis. Cell Biology International, 43(1), 44-55. https://doi.org/10.1002/cbin.11077"}, {"Citation": "Cui, Y., Zhang, F., Zhu, C., Geng, L., Tian, T., & Liu, H. (2017). Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/beta-catenin signaling pathway. Oncotarget, 8(11), 17785-17794. doi:10.18632/oncotarget.14854"}, {"Citation": "Cuneo, K. C., Morgan, M. A., Davis, M. A., Parcels, L. A., Parcels, J., Karnak, D., Liu, N., Maybaum, J., & Lawrence, T. S. (2016). Wee1 kinase inhibitor AZD1775 Radiosensitizes hepatocellular carcinoma regardless of TP53 mutational status through induction of replication stress. International Journal of Radiation Oncology, Biology, Physics, 95(2), 782-790. https://doi.org/10.1016/j.ijrobp.2016.01.028"}, {"Citation": "Fonseca, A. L., & Cha, C. H. (2014). Hepatocellular carcinoma: A comprehensive overview of surgical therapy. Journal of Surgical Oncology, 110(6), 712-719. https://doi.org/10.1002/jso.23673"}, {"Citation": "Gandellini, P., Rancati, T., Valdagni, R., & Zaffaroni, N. (2014). miRNAs in tumor radiation response: Bystanders or participants? Trends in Molecular Medicine, 20(9), 529-539. https://doi.org/10.1016/j.molmed.2014.07.004"}, {"Citation": "Garimella, S. V., Rocca, A., & Lipkowitz, S. (2012). WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis. Molecular Cancer Research, 10(1), 75-85. https://doi.org/10.1158/1541-7786.mcr-11-0500"}, {"Citation": "Girdhani, S., Bhosle, S. M., Thulsidas, S. A., Kumar, A., & Mishra, K. P. (2005). Potential of radiosensitizing agents in cancer chemo-radiotherapy. Journal of Cancer Research and Therapeutics, 1(3), 129-131. https://doi.org/10.4103/0973-1482.19585"}, {"Citation": "Hei, B., Wang, J., Wu, G., Ouyang, J., & Liu, R. E. (2019). Verbascoside suppresses the migration and invasion of human glioblastoma cells via targeting c-met-mediated epithelial-mesenchymal transition. Biochemical and Biophysical Research Communications, 514(4), 1270-1277. https://doi.org/10.1016/j.bbrc.2019.05.096"}, {"Citation": "Hou, Y., Li, L., Ju, Y., Lu, Y., Chang, L., & Xiang, X. (2017). MiR-101-3p regulates the viability of lung squamous carcinoma cells via targeting EZH2. Journal of Cellular Biochemistry, 118(10), 3142-3149. https://doi.org/10.1002/jcb.25836"}, {"Citation": "Jia, W. Q., Wang, Z. T., Zou, M. M., Lin, J. H., Li, Y. H., Zhang, L., & Xu, R. X. (2018). Verbascoside inhibits Glioblastoma cell proliferation, migration and invasion while promoting apoptosis through Upregulation of protein tyrosine phosphatase SHP-1 and inhibition of STAT3 phosphorylation. Cellular Physiology and Biochemistry, 47(5), 1871-1882. https://doi.org/10.1159/000491067"}, {"Citation": "Jothy, S. L., Chen, Y., Vijayarathna, S., Kanwar, J. R., & Sasidharan, S. (2015). MicroRNAs: Association with radioresistant and potential uses of natural remedies as green gene therapeutic approaches. Current Gene Therapy, 15(1), 15-20. https://doi.org/10.2174/1566523215666141205104117"}, {"Citation": "Klein, J., & Dawson, L. A. (2013). Hepatocellular carcinoma radiation therapy: Review of evidence and future opportunities. International Journal of Radiation Oncology, Biology, Physics, 87(1), 22-32. https://doi.org/10.1016/j.ijrobp.2012.08.043"}, {"Citation": "Li, C. Y., Pang, Y. Y., Yang, H., Li, J., Lu, H. X., Wang, H. L., Mo, W.-J., Huang, L.-S., Feng, Z.-B., & Chen, G. (2017). Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma. American Journal of Translational Research, 9(5), 2088-2105."}, {"Citation": "Li, C. Y., Xiong, D. D., Huang, C. Q., He, R. Q., Liang, H. W., Pan, D. H., Wang, H.-L., Wang, Y.-W., Zhu, H.-W., & Chen, G. (2017). Clinical value of miR-101-3p and biological analysis of its prospective targets in breast cancer: A study based on the cancer genome atlas (TCGA) and bioinformatics. Medical Science Monitor, 23, 1857-1871. doi:10.12659/msm.900030"}, {"Citation": "Li, Y., Yu, H., Jin, Y., Li, M., & Qu, C. (2018). Verbascoside alleviates atopic dermatitis-like symptoms in mice via its potent anti-inflammatory effect. International Archives of Allergy and Immunology, 175(4), 220-230. https://doi.org/10.1159/000486958"}, {"Citation": "Li, Z., Qu, Z., Wang, Y., Qin, M., & Zhang, H. (2020). miR-101-3p sensitizes non-small cell lung cancer cells to irradiation. Open Medicine (Wars), 15(1), 413-423. https://doi.org/10.1515/med-2020-0044"}, {"Citation": "Masaki, T., Shiratori, Y., Rengifo, W., Igarashi, K., Yamagata, M., Kurokohchi, K., Uchida, N., Miyauchi, Y., Yoshiji, H., Watanabe, S., Omata, M., & Kuriyama, S. (2003). Cyclins and cyclin-dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology, 37(3), 534-543. https://doi.org/10.1053/jhep.2003.50112"}, {"Citation": "Meng, X., Sun, Y., Liu, S., & Mu, Y. (2021). miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5. Oncology Letters, 21(4), 282. https://doi.org/10.3892/ol.2021.12543"}, {"Citation": "Mingardi, J., Musazzi, L., De Petro, G., & Barbon, A. (2018). miRNA editing: New insights into the fast control of gene expression in health and disease. Molecular Neurobiology, 55(10), 7717-7727. https://doi.org/10.1007/s12035-018-0951-x"}, {"Citation": "Mueller, S., & Haas-Kogan, D. A. (2015). WEE1 kinase as a target for cancer therapy. Journal of Clinical Oncology, 33(30), 3485-3487. https://doi.org/10.1200/jco.2015.62.2290"}, {"Citation": "P\u00e9rez-Romasanta, L. A., Gonz\u00e1lez-Del Portillo, E., Rodr\u00edguez-Guti\u00e9rrez, A., & Mat\u00edas-P\u00e9rez, \u00c1. (2021). Stereotactic radiotherapy for hepatocellular carcinoma, Radiosensitization strategies and radiation-immunotherapy combination. Cancers (Basel), 13(2), 192. https://doi.org/10.3390/cancers13020192"}, {"Citation": "PosthumaDeBoer, J., Wurdinger, T., Graat, H. C., van Beusechem, V. W., Helder, M. N., van Royen, B. J., & Kaspers, G. J. (2011). WEE1 inhibition sensitizes osteosarcoma to radiotherapy. BMC Cancer, 11, 156. https://doi.org/10.1186/1471-2407-11-156"}, {"Citation": "Qu, J. Q., Yi, H. M., Ye, X., Zhu, J. F., Yi, H., Li, L. N., Xiao, T., Yuan, L., Li, J.-Y., Wang, Y.-Y., Feng, J., He, Q.-Y., Lu, S.-S., & Xiao, Z. Q. (2015). MiRNA-203 reduces nasopharyngeal carcinoma Radioresistance by targeting IL8/AKT signaling. Molecular Cancer Therapeutics, 14(11), 2653-2664. https://doi.org/10.1158/1535-7163.mct-15-0461"}, {"Citation": "Ren, K., Li, Z., Li, Y., Zhang, W., & Han, X. (2017). Sulforaphene enhances radiosensitivity of hepatocellular carcinoma through suppression of the NF-kappaB pathway. Journal of Biochemical and Molecular Toxicology, 31(8), e21917. https://doi.org/10.1002/jbt.21917"}, {"Citation": "Seyfi, D., Behzad, S. B., Nabiuni, M., Parivar, K., Tahmaseb, M., & Amini, E. (2018). Verbascoside attenuates Rac-1 and HIF-1alpha signaling Cascade in colorectal cancer cells. Anti-Cancer Agents in Medicinal Chemistry, 18(15), 2149-2155. https://doi.org/10.2174/1871520618666180611112125"}, {"Citation": "Shao, Y., Song, X., Jiang, W., Chen, Y., Ning, Z., Gu, W., & Jiang, J. (2019). MicroRNA-621 acts as a tumor Radiosensitizer by directly targeting SETDB1 in hepatocellular carcinoma. Molecular Therapy, 27(2), 355-364. https://doi.org/10.1016/j.ymthe.2018.11.005"}, {"Citation": "Singh, S., Singh, P. P., Roberts, L. R., & Sanchez, W. (2014). Chemopreventive strategies in hepatocellular carcinoma. Nature Reviews. Gastroenterology & Hepatology, 11(1), 45-54. https://doi.org/10.1038/nrgastro.2013.143"}, {"Citation": "Slattery, M. L., Herrick, J. S., Pellatt, D. F., Mullany, L. E., Stevens, J. R., Wolff, E., Hoffman, M. D., Wolff, R. K., & Samowitz, W. (2016). Site-specific associations between miRNA expression and survival in colorectal cancer cases. Oncotarget, 7(37), 60193-60205. doi:10.18632/oncotarget.11173"}, {"Citation": "Stathis, A., & Oza, A. (2010). Targeting Wee1-like protein kinase to treat cancer. Drug News & Perspectives, 23(7), 425-429. https://doi.org/10.1358/dnp.2010.23.7.1490760"}, {"Citation": "Wang, B. F., Dai, Z. J., Wang, X. J., Bai, M. H., Lin, S., Ma, H. B., Wang, Y. L., Song, L. Q., Ma, X. L., Zan, Y., Min, W. L., & Cheng, Y. A. (2013). Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle. BMC Complementary and Alternative Medicine, 13, 263. https://doi.org/10.1186/1472-6882-13-263"}, {"Citation": "Wang, C., & Liu, B. (2018). miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2. Archives of Gynecology and Obstetrics, 297(6), 1539-1548. https://doi.org/10.1007/s00404-018-4768-7"}, {"Citation": "Wang, Y., Wang, C., Chen, C., Wu, F., Shen, P., Zhang, P., He, G., & Li, X. (2017). Long non-coding RNA NEAT1 regulates epithelial membrane protein 2 expression to repress nasopharyngeal carcinoma migration and irradiation-resistance through miR-101-3p as a competing endogenous RNA mechanism. Oncotarget, 8(41), 70156-70171. doi:10.18632/oncotarget.19596"}, {"Citation": "You, X., Cao, X., & Lin, Y. (2019). Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway. Frontiers in Bioscience (Landmark Ed), 24, 1190-1202. https://doi.org/10.2741/4775"}, {"Citation": "Zhang, P., Wang, L., Rodriguez-Aguayo, C., Yuan, Y., Debeb, B. G., Chen, D., Sun, Y., You, M. J., Liu, Y., Dean, D. C., Woodward, W. A., Liang, H., Yang, X., Lopez-Berestein, G., Sood, A. K., Hu, Y., Ang, K. K., Chen, J., & Ma, L. (2014). miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nature Communications, 5, 5671. https://doi.org/10.1038/ncomms6671"}, {"Citation": "Zhang, Y., Yuan, Y., Wu, H., Xie, Z., Wu, Y., Song, X., Wang, J., Shu, W., Xu, J., Liu, B., Wan, L., Yan, Y., Ding, X., Shi, X., Pan, Y., Li, X., Yang, J., Zhao, X., & Wang, L. (2018). Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma. International Journal of Cancer, 143(4), 980-991. https://doi.org/10.1002/ijc.31378"}, {"Citation": "Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., Han, G., Wang, M., Liu, R., Lu, L., Ren, Z., Chen, M., Zeng, Z., Liang, P., Liang, C., \u2026 Fan, J. (2020). Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer, 9(6), 682-720. https://doi.org/10.1159/000509424"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2021", "Month": "12", "Day": "30"}, {"Year": "2021", "Month": "7", "Day": "29"}, {"Year": "2022", "Month": "1", "Day": "9"}, {"Year": "2022", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "26", "Hour": "5", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35080031", "10.1002/ddr.21914"]}}], "PubmedBookArticle": []}